baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

CSL LTD/ AU000000CSL8 /

2024-11-07 6:29:02 PM	Chg. -	Volume	Bid10:01:45 PM	Ask10:01:45 PM	Market Capitalization	Dividend Y.	P/E Ratio
173.200EUR	-	17 Turnover: 2,947.820	172.900Bid Size: 41	174.660Ask Size: 40	85.11 bill.EUR	-	-

GlobeNewswire 08-09 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GRDI, BALY, CGBD on Behalf of Shareholders

GlobeNewswire 08-05 Carlyle Secured Lending, Inc. Announces Merger with Carlyle Secured Lending III

GlobeNewswire 08-05 Carlyle Secured Lending, Inc. Announces Financial Results For Second Quarter Ended 2024, Declares Th...

GlobeNewswire 08-01 Travere Therapeutics Reports Second Quarter 2024 Financial Results

GlobeNewswire 08-01 uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update

GlobeNewswire 07-16 Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer

GlobeNewswire 07-05 CSL Highlights Major ESG Achievements in 2023 Sustainability Report

GlobeNewswire 07-04 CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene The...

GlobeNewswire 07-02 CSL and BCI Minerals Partner to Build Advanced Transhipment Vessel for Mardie Project

GlobeNewswire 07-01 uniQure Announces Sale of Commercial Manufacturing Facility to Genezen

GlobeNewswire 06-14 Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of ...

GlobeNewswire 05-31 Immuron Board Changes

GlobeNewswire 05-22 Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-...

GlobeNewswire 05-13 Cara Therapeutics Reports First Quarter 2024 Financial Results

GlobeNewswire 05-09 ARS Pharmaceuticals Highlights neffy Regulatory Progress and Reports First Quarter 2024 Financial Re...

GlobeNewswire 05-08 Carlyle Secured Lending, Inc. Announces Financial Results For First Quarter Ended 2024, Declares Sec...

GlobeNewswire 05-07 uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

GlobeNewswire 05-07 Uniti Group Inc. Announces Pricing of Senior Secured Notes Offering

GlobeNewswire 05-06 Travere Therapeutics Reports First Quarter 2024 Financial Results

GlobeNewswire 05-06 Uniti Group Inc. Announces Private Offering of Senior Secured Notes

GlobeNewswire 05-01 Amarin Reports First Quarter 2024 Business Update and Financial Results

GlobeNewswire 04-30 EU Nephrologists Foresee Travere/CSL Vifor’s FILSPARITM (sparsentan) Transforming IgA Nephropathy Tr...

GlobeNewswire 04-30 Mark Cuban Foundation and CSL Bring AI Bootcamp to Philadelphia Teens

GlobeNewswire 04-30 ARS Pharmaceuticals Submits Response for neffy® (epinephrine nasal spray) Marketing Authorization Ap...

GlobeNewswire 04-24 Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...

CSL LTD/ AU000000CSL8 /

If you wish to receive reply to your feedback, please provide your email address.